Edgen Stock·Dec 16 2025, 14:01Back
Ligand Pharmaceuticals Issues Strong 2026 Financial Guidance
Edgen Stock·Dec 16 2025, 14:01
[1] 5 Of 2025’s Defining Clinical Wins - BioSpace (https://www.biospace.com/drug-development/5-o ...)[2] Aviceda Therapeutics Announces Phase 2b SIGLEC Results for AVD-104 in Geographic Atrophy - BioSpace (https://www.biospace.com/press-releases/avice ...)[3] Immunome to Announce Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors - BioSpace (https://www.biospace.com/press-releases/immun ...)
